Andrew Philip Witty is a British businessperson who has been at the helm of 8 different companies. Presently, Sir Witty holds the position of Group President at UnitedHealth Group, Inc. and Chief Executive Officer for InGensa, Inc. (a subsidiary of UnitedHealth Group, Inc.), Chief Executive Officer at GlaxoSmithKline, Inc. and Chief Executive Officer & Director at GlaxoSmithKline Australia Pty Ltd. Andrew Philip Witty is also on the board of Synthego Corp., Pharmaceutical Research & Manufacturers of America and G1 Therapeutics, Inc. and Member of Business Council for Britain and Chancellor at The University of Nottingham.
In his past career Sir Witty occupied the position of Chief Executive Officer & Executive Director at GlaxoSmithKline Plc Chief Executive Officer & Director at Genelabs Technologies, Inc. Managing Director at GlaxoSmithKline South Africa (Pty) Ltd. Area Director at Glaxo Wellcome South Africa Pty Ltd. Director-Pharmacy & Distribution at Glaxo Holdings Plc, Senior Vice President-Asia Pacific at GlaxoSmithKline Pte Ltd. and Vice President & General Manager-Marketing at Glaxo Wellcome, Inc. (which are all subsidiaries of GlaxoSmithKline Plc), Director-Business Development of Biocompatibles International Ltd., Member-International Advisory Council at Singapore Economic Development Board and Chairman for European Federation of Pharmaceutical Industries & Assns.
Andrew Philip Witty received an undergraduate degree from The University of Nottingham.